相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Predictive Factors of Adverse Events After Intravesical Suburothelial OnabotulinumtoxinA Injections for Overactive Bladder Syndrome-A Real-Life Practice of 290 Cases in a Single Center
Yuan-Hong Jiang et al.
NEUROUROLOGY AND URODYNAMICS (2017)
Retrograde transport of radiolabelled botulinum neurotoxin type A to the CNS after intradetrusor injection in rats
Dionysia Papagiannopoulou et al.
BJU INTERNATIONAL (2016)
Diagnosis and Treatment of Overactive Bladder (Non-Neurogenic) in Adults: AUA/SUFU Guideline Amendment
E. Ann Gormley et al.
JOURNAL OF UROLOGY (2015)
Trigonal versus extratrigonal botulinum toxin-A: a systematic review and meta-analysis of efficacy and adverse events
N. F. Davis et al.
INTERNATIONAL UROGYNECOLOGY JOURNAL (2015)
The Efficacy and Safety of OnabotulinumtoxinA in Treating Idiopathic OAB: A Systematic Review and Meta-Analysis
Yuanshan Cui et al.
NEUROUROLOGY AND URODYNAMICS (2015)
Pilot Study of Liposome-encapsulated OnabotulinumtoxinA for Patients with Overactive Bladder: A Single-center Study
Hann-Chorng Kuo et al.
EUROPEAN UROLOGY (2014)
Long-Term Adherence to Antimuscarinic Therapy in Everyday Practice: A Systematic Review
Paul W. Veenboer et al.
JOURNAL OF UROLOGY (2014)
OnabotulinumtoxinA 100 U Significantly Improves All Idiopathic Overactive Bladder Symptoms and Quality of Life in Patients with Overactive Bladder and Urinary Incontinence: A Randomised, Double-Blind, Placebo-Controlled Trial
Christopher Chapple et al.
EUROPEAN UROLOGY (2013)
OnabotulinumtoxinA for the Treatment of Patients with Overactive Bladder and Urinary Incontinence: Results of a Phase 3, Randomized, Placebo Controlled Trial
Victor W. Nitti et al.
JOURNAL OF UROLOGY (2013)
Prospective Randomised Controlled Trial Comparing Trigone-Sparing versus Trigone-Including Intradetrusor Injection of AbobotulinumtoxinA for Refractory Idiopathic Detrusor Overactivity
Rustom P. Manecksha et al.
EUROPEAN UROLOGY (2012)
OnabotulinumtoxinA Improves Health-Related Quality of Life in Patients With Urinary Incontinence Due to Idiopathic Overactive Bladder: A 36-Week, Double-Blind, Placebo-Controlled, Randomized, Dose-Ranging Trial
Clare J. Fowler et al.
EUROPEAN UROLOGY (2012)
Botulinum Toxin A Versus Placebo for Refractory Detrusor Overactivity in Women: A Randomised Blinded Placebo-Controlled Trial of 240 Women (the RELAX Study)
Douglas G. Tincello et al.
EUROPEAN UROLOGY (2012)
EAU Guidelines on Surgical Treatment of Urinary Incontinence
Malcolm G. Lucas et al.
EUROPEAN UROLOGY (2012)
Efficacy and Safety of Low Doses of OnabotulinumtoxinA for the Treatment of Refractory Idiopathic Overactive Bladder: A Multicentre, Double-Blind, Randomised, Placebo-Controlled Dose-Ranging Study
Pierre Denys et al.
EUROPEAN UROLOGY (2012)
Phase 3 Efficacy and Tolerability Study of OnabotulinumtoxinA for Urinary Incontinence From Neurogenic Detrusor Overactivity
David Ginsberg et al.
JOURNAL OF UROLOGY (2012)
Efficacy and Safety of OnabotulinumtoxinA in Patients with Urinary Incontinence Due to Neurogenic Detrusor Overactivity: A Randomised, Double-Blind, Placebo-Controlled Trial
Francisco Cruz et al.
EUROPEAN UROLOGY (2011)
The safety and efficacy of botulinum toxin-A in the management of bladder oversensitivity: a randomised double-blind placebo-controlled trial
C. Dowson et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2011)
Efficacy of Botulinum Toxin A Injection for Neurogenic Detrusor Overactivity and Urinary Incontinence: A Randomized, Double-Blind Trial
Sender Herschorn et al.
JOURNAL OF UROLOGY (2011)
Small Molecule Inhibitors as Countermeasures for Botulinum Neurotoxin Intoxication
Bing Li et al.
MOLECULES (2011)
Urodynamic Results and Clinical Outcomes With Intradetrusor Injections of OnabotulinumtoxinA in a Randomized, Placebo-Controlled Dose-Finding Study in Idiopathic Overactive Bladder
Eric Rovner et al.
NEUROUROLOGY AND URODYNAMICS (2011)
Bladder Base/Trigone Injection Is Safe and as Effective as Bladder Body Injection of OnabotulinumtoxinA for Idiopathic Detrusor Overactivity Refractory to Antimuscarinics
Hann-Chorng Kuo
NEUROUROLOGY AND URODYNAMICS (2011)
Urodynamic Detrusor Overactivity in Patients with Overactive Bladder Symptoms
Mohammed A. Al-Ghazo et al.
International Neurourology Journal (2011)
Efficacy and Safety of OnabotulinumtoxinA for Idiopathic Overactive Bladder: A Double-Blind, Placebo Controlled, Randomized, Dose Ranging Trial
Roger Dmochowski et al.
JOURNAL OF UROLOGY (2010)
Urinary Nerve Growth Factor Levels are Elevated in Patients with Detrusor Overactivity and Decreased in Responders to Detrusor Botulinum Toxin-A Injection
Hsin-Tzu Liu et al.
EUROPEAN UROLOGY (2009)
Outcome of a Randomized, Double-Blind, Placebo Controlled Trial of Botulinum A Toxin for Refractory Overactive Bladder
Michael K. Flynn et al.
JOURNAL OF UROLOGY (2009)
Neurogenic detrusor overactivity treated with English botulinum toxin A: 8-year experience of one single centre
Giulio Del Popolo et al.
EUROPEAN UROLOGY (2008)
Botulinum toxin A (Botox®) intradetrusor injections in adults with neurogenic detrusor overactivity/neurogenic overactive bladder:: A systematic literature review
Gilles Karsenty et al.
EUROPEAN UROLOGY (2008)
The effects of antimuscarinic treatments in overactive bladder: An update of a systematic review and meta-analysis
Christopher R. Chapple et al.
EUROPEAN UROLOGY (2008)
Refractory idiopathic urge urinary incontinence and botulinum A injection
Linda Brubaker et al.
JOURNAL OF UROLOGY (2008)
Prevalence and co-occurrence of pelvic floor disorders in community-dwelling women
Jean M. Lawrence et al.
OBSTETRICS AND GYNECOLOGY (2008)
Efficacy of botulinum. toxin-A for treating idiopathic detrusor overactivity: Results from a single center, randomized, double-blind, placebo controlled trial
Arun Sahai et al.
JOURNAL OF UROLOGY (2007)
Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: Results of the EPIC study
Debra E. Irwin et al.
EUROPEAN UROLOGY (2006)
Botulinum-A toxin injections into the detrusor muscle decrease nerve growth factor bladder tissue levels in patients with neurogenic detrusor overactivity
Antonella Giannantoni et al.
JOURNAL OF UROLOGY (2006)
SV2 is the protein receptor for botulinum neurotoxin A
M Dong et al.
SCIENCE (2006)
Decreased sensory receptors P2X3 and TRPV1 in suburothelial nerve fibers following intradetrusor injections of botulinum toxin for human detrusor overactivity
A Apostolidis et al.
JOURNAL OF UROLOGY (2005)
Botulinum toxin type A is a safe and effective treatment for neurogenic urinary incontinence:: Results of a single treatment, randomized, placebo controlled 6-month study
B Schurch et al.
JOURNAL OF UROLOGY (2005)
Success of repeat detrusor injections of botulinum A toxin in patients with severe neurogenic detrusor overactivity and incontinence
J Grosse et al.
EUROPEAN UROLOGY (2005)
Effect of botulinum toxin on detrusor overactivity induced by intravesical adenosine triphosphate and capsaicin in a rat model
H Atiemo et al.
UROLOGY (2005)
Parallel changes in bladder suburothelial vanilloid receptor TRPV1 and pan-neuronal marker PGP9.5 immunoreactivity in patients with neurogenic detrusor overactivity after intravesical resiniferatoxin treatment
CM Brady et al.
BJU INTERNATIONAL (2004)
Management of detrusor dysfunction in the elderly: Changes in acetylcholine and adenosine triphosphate release during aging
M Yoshida et al.
UROLOGY (2004)
Intravesical botulinum toxin A administration produces analgesia against acetic acid induced bladder pain responses in rats
YC Chuang et al.
JOURNAL OF UROLOGY (2004)
P2X3-immunoreactive nerve fibres in neurogenic detrusor overactivity and the effect of intravesical resiniferatoxin
CM Brady et al.
EUROPEAN UROLOGY (2004)
The role of the human bladder lamina propria myofibroblast
OJ Wiseman et al.
BJU INTERNATIONAL (2003)
The standardisation of terminology of lower urinary tract function: Report from the of the International Standardisation Sub-Committee Continence Society
P Abrams et al.
NEUROUROLOGY AND URODYNAMICS (2002)
Botulinum-a toxin for treating detrusor hyperreflexia in spinal cord injured patients: A new alternative to anticholinergic drugs? Preliminary results
B Schurch et al.
JOURNAL OF UROLOGY (2000)
分享论文
